A federal appeals court ruled Tuesday that genetic testing company 23andMe can't be sued over allegations that it misled customers about its test kit because the claims belong in arbitration.
Michelle Obama during her nearly eight years in the White House succeeded in changing the national conversation about diet and exercise, and gave a major boost to transparency about the foods we eat.
HHS Secretary Sylvia Mathews Burwell said she will divert federal funds to support efforts to develop a Zika vaccine.
The American Medical Association has partnered with Intermountain Healthcare and a health information technology firm in an effort to use digital health services to prevent Type 2 diabetes.
People in diverse corners of healthcare are hopeful new legislation will ease growing consumer anxiety over higher medical deductibles. And it might have a chance of becoming law because the cause comes from rare bipartisan ground.
Progress made over the past decade to improve the eating habits of U.S. adults has not narrowed racial and socioeconomic disparities, according to a new study.
Shortly after Anja Busse was diagnosed with Type 1 diabetes, the 11-year-old reached out to Mattel, the parent company of the American Girl dolls, with an idea.
Even as the White House touts the Affordable Care Act's successful coverage of nearly 20 million people, residents across the country are struggling to access and afford healthcare and social service programs.
David Dunlap, president and CEO of Roper St. Francis, announced he's retiring at the end of the year.
The technology uses an ingestible sensor, a wearable patch and a software application to track medication adherence.
This year, University of Illinois Hospital & Health Sciences System and partners are testing a program to reduce these costs. It is modeled on a strategy known as “Housing First” that is catching on across the country.
The CMS' decision this week to pay for the Diabetes Prevention Program is long overdue since its success in reducing obesity and thereby diabetes risk has been well documented in the medical and healthcare economics literature, and covered by certain sections of the press—like us.